Power to identify exposure‐response relationships in phase IIa pulmonary tuberculosis trials with multi‐dimensional bacterial load modeling
Abstract Adequate power to identify an exposure‐response relationship in a phase IIa clinical trial for pulmonary tuberculosis (TB) is important for dose selection and design of follow‐up studies. Currently, it is not known what response marker provides the pharmacokinetic‐pharmacodynamic (PK‐PD) mo...
Saved in:
Main Authors: | Simon E. Koele (Author), Thomas P. C. Dorlo (Author), Caryn M. Upton (Author), Rob E. Aarnoutse (Author), Elin M. Svensson (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combined quantitative tuberculosis biomarker model for time-to-positivity and colony forming unit to support tuberculosis drug development
by: Rami Ayoun Alsoud, et al.
Published: (2023) -
Health behaviour changes in partners of women with recent gestational diabetes: a phase IIa trial
by: Anne-Sophie Brazeau, et al.
Published: (2018) -
Survival analysis of Stage IIA1 and IIA2 cervical cancer patients
by: Jerry Cheng-Yen Lai, et al.
Published: (2013) -
Tumor Cell-Derived Exosomal Hybrid Nanosystems Loaded with Rhubarbic Acid and Tanshinone IIA for Sepsis Treatment
by: Wu Q, et al.
Published: (2024) -
Bacterial pneumonia score to identify bacterial pneumonia
by: Ied Imilda, et al.
Published: (2015)